Two‐dimensional transthoracic echocardiographic demonstration of reduction in fibrin content in purulent pericarditis following intrapericardial fibrinolytic agent administration
暂无分享,去创建一个
N. Nanda | Subash Dulal | M. Abdelsalam | C. Nathaniel | A. Ashiq | Zeyad M. Elmarzouky | C. Nathanial | Usama Habib | Maram Ahmed
[1] N. Nanda,et al. Two-dimensional transthoracic echocardiographic demonstration of reduction in fibrin content in purulent pericarditis following intrapericardial fibrinolytic agent administration. , 2021, Echocardiography.
[2] J. Rizk,et al. Acute purulent pericarditis treated conservatively with intrapericardial fibrinolysis and intrapericardial and systemic antibiotics , 2021, Proceedings.
[3] S. Sørensen,et al. Persistence and progression of staphylococcal infection in the presence of public goods , 2020, NPJ biofilms and microbiomes.
[4] W. Tomkowski,et al. Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series , 2020, BMC Cardiovascular Disorders.
[5] A. Wiyeh,et al. A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion. , 2018, International journal of cardiology.
[6] K. Swedberg,et al. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. , 2015, Revista espanola de cardiologia.
[7] P. Kuca,et al. Intrapericardial fibrinolysis in purulent pericarditis—case report , 2015, International Journal of Emergency Medicine.
[8] T. Corrah,et al. Management of persistent purulent pericarditis using streptokinase for intrapericardial fibrinolysis , 2014, Paediatrics and international child health.
[9] Y. Adler,et al. Management of pericardial effusion. , 2013, European heart journal.
[10] P. Mordant,et al. Clinical review: Intrapericardial fibrinolysis in management of purulent pericarditis , 2011, Critical care.
[11] L. Sinak,et al. Pericardial disease: diagnosis and management. , 2010, Mayo Clinic proceedings.
[12] H. Wong,et al. Therapeutic application of intrapericardial tissue plasminogen activator in a 4-month-old child with complex fibropurulent pericarditis , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[13] G. Guan,et al. Prevention of pericardial constriction by transcatheter intrapericardial fibrinolysis with urokinase. , 2005, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[14] M. Kurzyna,et al. Effectiveness of Intrapericardial Administration of Streptokinase in Purulent Pericarditis , 2004, Herz.
[15] R. Demirbağ,et al. Intrapericardial Streptokinase for Purulent Pericarditis , 2004, Surgery Today.
[16] J. Fish,et al. Pericardial Infusion of Tissue Plasminogen Activator in Fibropurulent Pericarditis , 2003, Journal of intensive care medicine.
[17] A. Delabays,et al. Intrapericardial Urokinase Irrigation and Systemic Corticosteroids: An Alternative to Pericardectomy for Persistent Fibrino-Purulent Pericarditis , 2002, Cardiovascular surgery.
[18] B. Dikici,et al. Purulent pericarditis in childhood: ten years of experience. , 2002, Journal of pediatric surgery.
[19] M. Kılınç,et al. Intrapericardial fibrinolytic therapy in purulent pericarditis. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] G. Meyer,et al. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis , 1997, Intensive Care Medicine.
[21] E. Shanahan,et al. Purulent pericarditis: rediscovery of an old remedy. , 1996, The Journal of thoracic and cardiovascular surgery.
[22] J. Slany,et al. Treatment of exudative fibririous pericarditis with intrapericardial urokinase , 1994, The Lancet.
[23] E. Silove,et al. Use of streptokinase to aid in drainage of postoperative pericardial effusion. , 1989, British heart journal.